Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma
Clinical trial NCT03364231 · COMPLETED
Trial details
- NCT number
- NCT03364231
- Sponsor
- TG Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2022-02-15
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.